Chorokbaem Healthcare Co Ltd (118000) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Chorokbaem Healthcare Co Ltd (118000) has a cash flow conversion efficiency ratio of 0.023x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.85 Billion ≈ $1.93 Million USD) by net assets (₩121.63 Billion ≈ $82.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Chorokbaem Healthcare Co Ltd (118000) net asset quality to measure how much of total assets are equity-financed.
Chorokbaem Healthcare Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Chorokbaem Healthcare Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 118000 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Chorokbaem Healthcare Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chorokbaem Healthcare Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Palatin Technologies, Inc. Common Stock
NASDAQ:PTN
|
-0.417x |
|
Floyd Public Company Limited
BK:FLOYD
|
0.048x |
|
PROSTAR HOLDINGS INC.
F:5D00
|
0.360x |
|
FORIS AG
F:FRS
|
-0.097x |
|
RPCG Public Company Limited
BK:RPC
|
0.061x |
|
Boule Diagnostics AB
ST:BOUL
|
-0.017x |
|
Mobotix AG
F:MBQ
|
N/A |
|
Wetouch Technology Inc. Common Stock
NASDAQ:WETH
|
0.004x |
Annual Cash Flow Conversion Efficiency for Chorokbaem Healthcare Co Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Chorokbaem Healthcare Co Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 118000 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩120.98 Billion ≈ $81.99 Million |
₩2.42 Billion ≈ $1.64 Million |
0.020x | -47.82% |
| 2024-12-31 | ₩116.80 Billion ≈ $79.15 Million |
₩4.48 Billion ≈ $3.03 Million |
0.038x | +141.05% |
| 2023-12-31 | ₩137.70 Billion ≈ $93.32 Million |
₩-12.86 Billion ≈ $-8.71 Million |
-0.093x | -378.38% |
| 2022-12-31 | ₩129.58 Billion ≈ $87.81 Million |
₩-2.53 Billion ≈ $-1.71 Million |
-0.020x | -56.24% |
| 2021-12-31 | ₩119.40 Billion ≈ $80.92 Million |
₩-1.49 Billion ≈ $-1.01 Million |
-0.012x | -125.06% |
| 2020-12-31 | ₩76.13 Billion ≈ $51.59 Million |
₩3.79 Billion ≈ $2.57 Million |
0.050x | +43.90% |
| 2019-12-31 | ₩35.94 Billion ≈ $24.35 Million |
₩1.24 Billion ≈ $843.66K |
0.035x | +123.68% |
| 2018-12-31 | ₩18.51 Billion ≈ $12.54 Million |
₩-2.71 Billion ≈ $-1.84 Million |
-0.146x | +78.43% |
| 2017-12-31 | ₩18.71 Billion ≈ $12.68 Million |
₩-12.69 Billion ≈ $-8.60 Million |
-0.678x | -87.81% |
| 2016-12-31 | ₩13.44 Billion ≈ $9.11 Million |
₩-4.85 Billion ≈ $-3.29 Million |
-0.361x | +37.24% |
| 2015-12-31 | ₩6.19 Billion ≈ $4.19 Million |
₩-3.56 Billion ≈ $-2.41 Million |
-0.575x | +8.39% |
| 2014-12-31 | ₩8.32 Billion ≈ $5.64 Million |
₩-5.22 Billion ≈ $-3.54 Million |
-0.628x | -4003.37% |
| 2013-12-31 | ₩16.04 Billion ≈ $10.87 Million |
₩258.12 Million ≈ $174.92K |
0.016x | -- |
About Chorokbaem Healthcare Co Ltd
METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more